Study Details
Single dose study to measure blood levels and safety of a drug for children with overactive bladder
Clinicaltrials.gov ID
Astellas Study ID
905-CL-079
EudraCT ID
2011-000250-28
Condition
Overactive Bladder Disease, Bladder Disease
Phase
Phase 1
Age
5 years - 17 years
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Mar 2012 - Aug 2012
Masking
None (Open Label)
Enrollment number
14
A Multicenter, Open-label, Single-dose Study to Evaluate Pharmacokinetics, Safety and Tolerability of Solifenacin Succinate Suspension in Pediatric Subjects from 5 to less than 18 years of age with Neurogenic Detrusor Overactivity (NDO)
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Single dose study to measure blood levels and safety of a drug for children with overactive bladder? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site: 3201
Gent, Belgium, 9000
Québec City, Canada, G1V 4G2
Site: 4801
Warszawa, Poland, 04-730
Site: 90
Ankara, Turkey, 6100
Site: 3102
Utrecht, Netherlands, 3584 EA
Site: 4501
Århus N, Denmark, DK-8200
Site: 44
Sheffield, United Kingdom, S10 2TH